Table III.
cAMP targets
| Molecule | assay | experimental approach | Refs |
|---|---|---|---|
| PKA | Presence in sperm flagella | WB, IF, PKA activity and cAMP measurements | 41 |
| Activation during capacitation | WB | 44,47,48,49,50,51 | |
| Dependence on sAC | Loss of function sAC KO | 52 | |
| Role in tyrosine phosphorylation | Loss and gain of function experiments with PKA Inhibitors and cAMP permeable analogs | 35 | |
| Role in capacitation and sperm motility | Loss of function by pharmacological and genetic knock-out approaches targeting sAC, the PKA catalytic subunit or the anchoring of PKA to AKAPs | 35,49,91, 119 | |
| CNGs | Presence in sperm | Cloning, electrophisiological characterization, Ca2+ imaging and patch clamp recording | 144,145 |
| Role in chemotaxis | Sperm motility recording, fluorescent dyes, Caged compounds and flash photolysis techniques | 142,143 | |
| Increase [Ca2+]i in sperm | Ca2+ imaging | 146,147 | |
| EPAC | Presence in sperm and involvement in acrosome reaction | Gain of function by EPAC-selective cAMP analogs, acrosome reaction measurements, WB, Immunofluorescence | 27,56,151,152 |
| NHE | Presence in sperm and role in internal alkalinization and hyperpolarization | Loss of function by NHE-targeted deletion | 31 |
| Experiments with pHi-sensitive fluorescence probes | 21 | ||
| Role in sAC expresion during spermiogenesis | Loss of function NHE KO | 32 |
Abbreviations: WB: Western Blot; IF: immunofluorescence